Organization Overview
Alternative names
acetylsalicylic acid (aspirin) (1 trial)
alectinib (alecensa) (2 trials)
anastrozole (arimidex) (3 trials)
atezolizumab (Tecentriq) (4 trials)
autologous hematopoietic stem cells (3 trials)
bevacizumab (avastin) (4 trials)
bleomycin (blenoxane) (3 trials)
bone marrow derived mesenchymal stem cells (1 trial)
capecitabine (xeloda) (10 trials)
carboplatin (paraplatin) (16 trials)
cetuximab (erbitux) (2 trials)
cisplatin (platinol) (20 trials)
cladribine (leustatin) (1 trial)
cytarabine (cytosar-u) (5 trials)
dacarbazine (dtic-dome) (2 trials)
darbepoetin alfa (aranesp) (1 trial)
daunorubicin (cerubidine) (1 trial)
docetaxel (taxotere) (2 trials)
doxorubicin (Doxil) (8 trials)
durvalumab (imfinzi) (4 trials)
entrectinib (Rozlytrek) (2 trials)
epirubicin (ellence) (2 trials)
erlotinib (tarceva) (2 trials)
etoposide (vepesid) (9 trials)
Filgrastim (neupogen) (3 trials)
fludarabine (fludara) (9 trials)
fluorouracil (efudex) (10 trials)
Fosgemcitabine (acelarin) (1 trial)
ibandronate (boniva) (1 trial)
inotuzumab ozogamicin (besponsa) (2 trials)
lenalidomide (revlimid) (3 trials)
levoleucovorin (fusilev) (1 trial)
loncastuximab (Zynlonta) (1 trial)
medroxyprogesterone (provera) (1 trial)
melphalan (alkeran) (7 trials)
mitomycin (mutamycin) (1 trial)
mitoxantrone (novantrone) (2 trials)
octreotide (sandostatin) (1 trial)
paclitaxel (taxol) (21 trials)
pertuzumab (perjeta) (2 trials)
prednisone (meticorten) (8 trials)
procarbazine (matulane) (1 trial)
quizartinib (VANFLYTA) (1 trial)
rituximab (rituxan) (11 trials)
sargramostim (leukine) (6 trials)
tamoxifen (nolvadex) (4 trials)
thalidomide (Thalomid) (4 trials)
trastuzumab (herceptin) (3 trials)
vemurafenib (zelboraf) (2 trials)
vinblastine (velban) (2 trials)
124i-meta-iodobenzylguanidine (1 trial)
[18f]fluoropivalate ([18f]fluoro-2,2-dimethylpropionic acid) (1 trial)
abiraterone (zytiga) (1 trial)
alemtuzumab (campath) (4 trials)
allogeneic hematopoietic stem cells (Hemacord) (3 trials)
allogeneic lymphocytes (3 trials)
autologous umbilical cord blood (1 trial)
bis-choline tetrathiomolybdate (1 trial)
chadox1-magea3-nyeso (1 trial)
choline c11 (choline c-11) (1 trial)
crizotinib (xalkori) (1 trial)
cyclosporine (sandimmune) (3 trials)
decitabine (dacogen) (1 trial)
Epcoritamab (Epkinly) (1 trial)
everolimus (zortress) (1 trial)
exemestane (aromasin) (2 trials)
fluoromethylcholine (18f) (FCH) (1 trial)
fulvestrant (faslodex) (2 trials)
hydroxychloroquine (plaquenil) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
irinotecan (Camptosar) (3 trials)
methylprednisolone (medrol) (1 trial)
modified vaccinia ankara-5t4 vaccine (2 trials)
mycophenolate (CellCept) (1 trial)
nelfinavir (viracept) (1 trial)
obinutuzumab (gazyva) (1 trial)
ofatumumab (arzerra) (1 trial)
osimertinib (tagrisso) (1 trial)
pegylated arginine deiminase (1 trial)
pembrolizumab (keytruda) (4 trials)
selumetinib (Koselugo) (6 trials)
se-methyl-seleno-l-cysteine (1 trial)
sitagliptin (januvia) (1 trial)
temozolomide (temodar) (3 trials)
topotecan (hycamtin) (2 trials)
vandetanib (caprelsa) (3 trials)
Adenocarcinoma (Phase 3)
Adenocarcinoma, Clear Cell (Phase 2)
Adenomyoepithelioma (Phase 2)
Anus Neoplasms (Phase 2)
Biliary Tract Neoplasms (Phase 3)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 3)
Burkitt Lymphoma (Phase 1)
Carcinoma (Phase 3)
Carcinoma, Acinar Cell (Phase 3)
Carcinoma in Situ (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 3)
Carotid Body Tumor (Phase 1)
Central Nervous System Neoplasms (Phase 1)
Cholangiocarcinoma (Phase 3)
Choriocarcinoma (Phase 3)
Colorectal Neoplasms (Phase 3)
Dementia (Phase 3)
Disease Progression (Phase 3)
Endodermal Sinus Tumor (Phase 3)
Endometrial Neoplasms (Phase 3)
Enteropathy-Associated T-Cell Lymphoma (Phase 2)
Epstein-Barr Virus Infections (Phase 1)
Esophageal Neoplasms (Phase 3)
Fallopian Tube Neoplasms (Phase 3)
Frailty (Phase 3)
Gallbladder Neoplasms (Phase 3)
Germinoma (Phase 3)
Glioblastoma (Phase 2)
Head and Neck Neoplasms (Phase 3)
Hemangiosarcoma (Phase 2)
Hodgkin Disease (Phase 3)
Immunoblastic Lymphadenopathy (Phase 2)
Intestinal Neoplasms (Phase 2)
Kidney Neoplasms (Phase 3)
Laryngeal Neoplasms (Phase 1)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 3)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphoproliferative Disorders (Phase 1)
Melanoma (Phase 2)
Mesothelioma (Phase 2)
Mucositis (Phase 2)
Multiple Myeloma (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Nasopharyngeal Carcinoma (Phase 1)
Nasopharyngeal Neoplasms (Phase 1)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Nervous System Neoplasms (Phase 1)
Neuroblastoma (Phase 2)
Neuroendocrine Tumors (Phase 1)
Neurotoxicity Syndromes (Phase 2)
Oropharyngeal Neoplasms (Phase 1)
Ovarian Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 3)
Paraganglioma (Phase 1)
Parkinson Disease (Phase 3)
Pheochromocytoma (Phase 1)
Plasmacytoma (Phase 3)
Preleukemia (Phase 3)
Prostatic Neoplasms (Phase 3)
Rectal Neoplasms (Phase 3)
Sarcoma (Phase 2)
Sarcoma, Kaposi (Phase 2)
Seminoma (Phase 3)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 1)
Syndrome (Phase 3)
Teratoma (Phase 3)
Testicular Neoplasms (Phase 3)
Thyroid Diseases (Phase 3)
Thyroid Neoplasms (Phase 3)
Triple Negative Breast Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 3)
Uterine Cervical Neoplasms (Phase 3)
Uveal Neoplasms (Phase 2)
Virus Diseases (Phase 1)
Waldenstrom Macroglobulinemia (Phase 2)
